Skip to main content
editorial
. 2019 Jan 13;9(7):1200–1208. doi: 10.1002/jcsm.12379

Table 1.

Association between body mass index (BMI) at cancer diagnosis and overall survival

Cancer site or type Relative risk of the overweight/obese BMI category evaluated vs. normal BMI (95% CI)
Myeloid leukemia94 0.47 (0.26–0.82)
Non‐metastatic colorectal65 0.52 (0.35–0.77)
Metastatic melanomaa, 29 0.72 (0.57–0.91)
Lymphoma95 0.76 (0.67–0.86)
Gastric96 0.76 (0.59–0.99)
Renal97 0.84 (0.73–0.95)
Metastatic colorectal28 ≈0.90 (≈0.85–0.95)
a

Among patients treated with targeted therapy